Inside Innovation

Washington is the fourth-best state in the U.S. for remote job seekers, according to a new study by CareerCloud. This ranking is based on data

Vancouver, Washington-based AbSci raised $125 million in a recent funding round, bringing the company’s total funding up to $230 million. The capital will further AbSci’s growth

Seattle startup Curi Bio raised $6 million in a Series A funding round to further develop its human stem cell-based platforms for drug discovery. The

Eliem Therapeutics, a clinical stage biotechnology company focused on developing therapies for neuronal excitability disorders, emerged from stealth with $80 million in capital and two

Bristol Myers Squibb’s Bothell manufacturing facility has been designated as one of the production facilities for the company’s newly-approved cancer treatment, Breyanzi. The facility has

Seattle’s life science cluster has been named the fifth-best in America according to a report by commercial real estate firm Newmark. The report emphasized the

Nearly 12 months after experiencing the U.S.’s first widespread COVID-19 outbreak, Seattle has recorded the lowest COVID-related death rate of the 20 largest metropolitan regions

For the second year in a row, Washington has been named the best state in the U.S. by U.S. News & World Report. The 2021

Seattle came in at No. 8 on Genetic Engineering & Biotechnology News’ list of the top 10 U.S. life science clusters. The ranking is based

Photon Biosciences, a Spokane Valley-based startup, is developing a new class of probe molecules that can be applied to various biological imaging and diagnostic applications.

Seattle-based Phase Genomics has been awarded a $1.7 million grant from the National Institutes of Health. The funding will go toward creating a platform for

Adaptive Biotechnologies recently launched a new COVID-19 test that searches for T-cell responses against the virus, providing a more accurate way to detect prior infections.